Content about Sulfoxides

May 24, 2010

Prolonged use of a common class of drugs for treating digestive problems may increase the...

SILVER SPRING, Md. Prolonged use of a common class of drugs for treating digestive problems may increase the risk of bone fractures, the Food and Drug Administration said Tuesday.

The FDA issued a warning to consumers and healthcare professionals based on a review of several epidemiological studies that long-term use of prescription and OTC proton-pump inhibitors or use of the drugs in high doses could increase the risk of fractures of the hip, wrist and spine. Information about the possible risks will be included on revised product labels for PPIs, the FDA said.

May 2, 2010

The Food and Drug Administration has approved a drug by AstraZeneca and Pozen for treating...

March 29, 2010

The Federal Trade Commission’s crusade against patent settlements between branded and generic drug makers moved...

March 29, 2010

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

March 14, 2010

By the end of this quarter, there shouldn’t be one person in America who doesn’t...

February 28, 2010

AstraZeneca plans to buy Merck & Co.’s interest in several drug products that the two...

January 24, 2010

A generic version of a gastroesophageal reflux disease drug that dissolves in the mouth doesn’t...

January 10, 2010

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 10, 2010

This is shaping up to be a Fight Night dream card, with the battle arena...

WHAT IT MEANS AND WHY IT'S IMPORTANT This is shaping up to be a Fight Night dream card, with the battle arena located in the digestives aisle of a pharmacy near you. Are you ready to rumble?

(THE NEWS: P&G develops new program in line with Prilosec OTC. For the full story, click here)

January 6, 2010

Teva announced Thursday that it has entered into two definitive agreements with AstraZeneca to settle...

January 5, 2010

Watson has filed an abbreviated new drug application for the generic version of a sleep...

December 3, 2009

The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump...

NEW YORK The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump inhibitors on the shelf. And while there may be some question as to just how large sales of antacids can get, one thing is for sure: There will be a slew of advertisers vying for their own increased share of stomach.